RFC4 and pancreatic adenocarcinoma: The analysis of the GEPIA database demonstrated a significant correlation between RFC4 expression and a more unfavorable prognosis in ACC, KIRP, LIHC, and PAAD, as observed in DFS and OS outcomes.